Format
Sort by

Send to:

Choose Destination

Results: 2

1.

Extending and evaluating a warfarin dosing algorithm that includes CYP4F2 and pooled rare variants of CYP2C9.

Sagreiya H, Berube C, Wen A, Ramakrishnan R, Mir A, Hamilton A, Altman RB.

Pharmacogenet Genomics. 2010 Jul;20(7):407-13. doi: 10.1097/FPC.0b013e328338bac2. Erratum in: Pharmacogenet Genomics. 2010 Oct;20(10):645. Sagrieya, Hersh [corrected to Sagreiya, Hersh].

2.

Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups.

Limdi NA, Wadelius M, Cavallari L, Eriksson N, Crawford DC, Lee MT, Chen CH, Motsinger-Reif A, Sagreiya H, Liu N, Wu AH, Gage BF, Jorgensen A, Pirmohamed M, Shin JG, Suarez-Kurtz G, Kimmel SE, Johnson JA, Klein TE, Wagner MJ; International Warfarin Pharmacogenetics Consortium.

Blood. 2010 May 6;115(18):3827-34. doi: 10.1182/blood-2009-12-255992. Epub 2010 Mar 4.

Supplemental Content

Loading ...
Write to the Help Desk